Screener
Aurinia Pharmaceuticals AUPH Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued sales rebates and fees | $40,330 | $30,832 |
| Accrued payroll and related expenses | 11,842 | 18,869 |
| Accrued research and development expenses | 5,634 | 6,127 |
| Accrued sales and marketing expenses | 1,304 | 1,648 |
| Accrued corporate and excise taxes | 860 | 2,010 |
| Accrued other expenses | 4,142 | 7,135 |
| Total accrued expenses | $64,112 | $66,621 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's accrued expenses?
- Aurinia Pharmaceuticals (AUPH) reported accrued expenses of $11.84M in Q2 2026.
- How has Aurinia Pharmaceuticals's accrued expenses changed year-over-year?
- Aurinia Pharmaceuticals's accrued expenses increased by 63.2% year-over-year, from $7.26M to $11.84M.
- What is the long-term trend for Aurinia Pharmaceuticals's accrued expenses?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's accrued expenses has grown at a 24.1% compound annual growth rate (CAGR), from $6.41M to $18.87M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Aurinia Pharmaceuticals's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude